anmelden
FTSE 100
10.816,56
PKT
+68,40
PKT
+0,64
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.04.17 | Imperial Brands Neutral | Citigroup Corp. | |
| 28.04.17 | Vodafone Group buy | Deutsche Bank AG | |
| 28.04.17 | BT Group Sell | Deutsche Bank AG | |
| 28.04.17 | Lloyds Banking Group overweight | Barclays Capital | |
| 28.04.17 | AstraZeneca buy | Deutsche Bank AG | |
| 28.04.17 | AstraZeneca market-perform | Bernstein Research | |
| 28.04.17 | Barclays Sector Perform | Robert W. Baird & Co. Incorporated | |
| 28.04.17 | AstraZeneca Reduce | HSBC | |
| 27.04.17 | AstraZeneca Sell | S&P Capital IQ | |
| 27.04.17 | Lloyds Banking Group Outperform | Robert W. Baird & Co. Incorporated | |
| 27.04.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.04.17 | Lloyds Banking Group overweight | Barclays Capital | |
| 27.04.17 | AstraZeneca Neutral | UBS AG | |
| 27.04.17 | GSK buy | Goldman Sachs Group Inc. | |
| 27.04.17 | Standard Chartered buy | Goldman Sachs Group Inc. | |
| 27.04.17 | GSK Neutral | UBS AG | |
| 27.04.17 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 27.04.17 | GSK Hold | Deutsche Bank AG | |
| 26.04.17 | London Stock Exchange (LSE) Outperform | Robert W. Baird & Co. Incorporated | |
| 26.04.17 | BT Group Outperform | Robert W. Baird & Co. Incorporated | |
| 26.04.17 | London Stock Exchange (LSE) overweight | Barclays Capital | |
| 25.04.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 25.04.17 | London Stock Exchange (LSE) Neutral | JP Morgan Chase & Co. | |
| 25.04.17 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 25.04.17 | Vodafone Group Conviction Buy | Goldman Sachs Group Inc. | |
| 25.04.17 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 25.04.17 | BT Group Neutral | Goldman Sachs Group Inc. | |
| 25.04.17 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 25.04.17 | BP buy | Deutsche Bank AG | |
| 25.04.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 25.04.17 | BP buy | UBS AG | |
| 25.04.17 | International Consolidated Airlines buy | UBS AG | |
| 25.04.17 | HSBC Hold | Deutsche Bank AG | |
| 24.04.17 | Lloyds Banking Group Neutral | Macquarie Research | |
| 24.04.17 | Barclays Underperform | Macquarie Research | |
| 24.04.17 | AstraZeneca overweight | Morgan Stanley | |
| 24.04.17 | BP overweight | Morgan Stanley | |
| 24.04.17 | Shell (ex Royal Dutch Shell) overweight | Morgan Stanley | |
| 24.04.17 | Diageo overweight | JP Morgan Chase & Co. | |
| 24.04.17 | Associated British Foods overweight | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
